Gene expression profiling for identification, monitoring, and treatment of prostate cancer

Details for Australian Patent Application No. 2007350331 (hide)

Owner Source Precision Medicine, Inc. d/b/a Source MDX

Inventors Wassmann, Karl; Storm, Kathleen; Bankaitis-Davis, Danute; Siconolfi, Lisa

Agent Cullen & Co

Pub. Number AU-A-2007350331

PCT Pub. Number WO2008/121132

Priority 60/920,931 30.03.07 US; 60/965,121 17.08.07 US

Filing date 6 November 2007

Wipo publication date 9 October 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/121132 Priority application(s): WO2008/121132

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007350336-Fabrication of microstructures and nanostructures using etching resist

2007350326-Non-peptidic molecules for detecting and treating tumors